Zelboraf 240 mg, Filmtabletten

7680621390013 CH-62139 Filmtabletten
Zelboraf 240 mg, Filmtabletten
Zelboraf 240 mg, Filmtabletten
1 / 2
google

Article details

Package size
56
Selling units
56
Measure
Tablette(n)
Galenic form
Filmtabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
12/06/2025
Patient information leaflet
Français
12/06/2025
Patient information leaflet
Italien
12/06/2025
Summary of Product Characteristics
Allemand
12/06/2025
Summary of Product Characteristics
Français
12/06/2025
Summary of Product Characteristics
Italien
12/06/2025

Detailed composition

Substance Quantity Type Category
(N/A)
240.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance FTODK
(N/A)
5.6 MG Substance HBESI

Reimbursement information

Public price
CHF 1610.65
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/04/2012

Authorization holder

Roche Pharma (Schweiz) AG

4058 Basel

Authorization information

Swissmedic authorization number
62139
Drug name
Zelboraf, Filmtabletten
Galenic form
FILM
ATC Code
L01EC01
Authorization status
Z
Dispensing category
A
First authorization
18/10/2011
Authorization expiration date
31/12/9999
IT Number
07.16.1.
Domain
Human medicine
Field of application
Behandlung von nicht resezierbaren oder metastasierten Melanom Patienten mit einer BRAF V600 Mutation

Package details

Description (FR)
ZELBORAF cpr pel 240 mg 56 pce
Description (DE)
ZELBORAF Filmtabl 240 mg 56 Stk
Market launch
18/10/2011
Narcotic (BTM)
No